Decision making in critically ill patients with hematologic malignancy.
Hematologic neoplasms that were previously considered fatal are now potentially curable with techniques such as bone marrow transplantation. Such therapies also carry significant morbidity and mortality. With the increasing application of these therapies, a growing number of physicians are using medical decision making regarding critical care for these patients. The process by which ethical decisions are reached for these critically ill patients may be baffling because of several factors: rapidly evolving treatments, uncertain probabilities of the cure of the malignant disorder, the relatively young age of many of these patients, and the poor prognosis with critical illness. I discuss a process to reach acceptable decisions, providing a case example of the application of the process. This process is derived from the ethical principles that drive decision making in general medicine and attempts to maximize patients' autonomy. It involves a consideration of accurate information regarding the disease process and the prognosis, a clear delineation of the goals of the medical care, and communication with patients. Appropriate, ethical, and consistent decisions regarding the critical care of patients with hematologic malignancy can be reached when these considerations are addressed.
Crawford
S W
SW
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
D000328:Adult; D026686:Beneficence; D016026:Bone Marrow Transplantation; D016638:Critical Illness; D003657:Decision Making; D030881:Disclosure; D028741:Ethics Committees, Clinical; D004992:Ethics, Medical; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D015470:Leukemia, Myeloid, Acute / Q000601:surgery; D008297:Male; D018579:Patient Selection; D026684:Personal Autonomy; D011379:Prognosis; D011788:Quality of Life; D018570:Risk Assessment; D013315:Stress, Psychological; D035501:Uncertainty; D028761:Withholding Treatment